Vitamin D3 shows promise for IBD symptom relief in new study
NCT ID NCT04225819
First seen May 01, 2026 · Last updated May 29, 2026 · Updated 5 times
Summary
This study tests whether adding vitamin D3 to standard anti-TNF therapy can improve symptoms and quality of life in people with active inflammatory bowel disease (IBD), including Crohn's disease and ulcerative colitis. About 100 participants will receive either vitamin D3 or a placebo for 14 weeks. The goal is to see if vitamin D3 helps reduce disease activity and improve well-being.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CROHN DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
Conditions
Explore the condition pages connected to this study.